Rituxan 500 mg/50 mL solution for intravenous infusion Images
Generic Name: rituximab
This medication has been identified as Rituxan 500 mg/50 mL solution for intravenous infusion. It is supplied by Genentech, Inc.
Rituxan is used in the treatment of Follicular Lymphoma; Granulomatosis with Polyangiitis; Chronic Lymphocytic Leukemia; Microscopic Polyangiitis; Non-Hodgkin's Lymphoma and belongs to the drug classes antirheumatics, CD20 monoclonal antibodies. Risk cannot be ruled out during pregnancy. Rituxan 500 mg/50 mL solution for intravenous infusion is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Rituxan
- Generic Name
- rituximab
- Strength
- 500 mg/50 mL solution for intravenous infusion
- Availability
- Prescription only
- Drug Class
- Antirheumatics, CD20 monoclonal antibodies
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Genentech, Inc.
- National Drug Code (NDC)
- 50242-0053
More about Rituxan (rituximab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (52)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: antirheumatics
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.